Skip to main content
IMS Events Main banner
Back

    María-Victoria Mateos, MD, PhD

    Professor
    University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
    Salamanca, Spain

    Dr. María-Victoria Mateos, MD, PhD, is Head of Unit n in the Haematology Department and Professor of Medicine at the University of Salamanca, Spain. She is the director of the Myeloma Program and coordinates the Clinical Trials Unit.
    She serves as coordinator of GEM (Spanish Myeloma Group), with direct involvement in the design and development of clinical trials. She has coordinated many clinical trials especially in the setting of transplant ineligible and smouldering myeloma and these trials have profoundly influenced current options for the management of these patient populations.
    She has published over 300 l papers in international journals with a H index of 79 and 60 since 2015.
    She is also a member of the IMWG (International MM Working Group), IMS (International MM Society), EHA and ASH.
    She has served on the ASH Scientific Committee on plasma cell diseases between 2015-2019 and on the EHA’s Scientific Program Committee and Advisory Board since 2013 until 2020 being chair of the Scientific Program Committee in 2019.
    She has been Councillor on the EHA Board since 2015 for a four-year mandate and she remains as member of the IMS executive board and member of the European School of Haematology (ESH) Scientific committee. She received the Briand Durie Award in 2019 recognizing excellence in myeloma research and the life time Kyle award in 2023.

    Disclosure information not submitted.

    Presentation(s):